SUMMARY Three children with nephropathic cystinosis were treated with indomethacin 3 mg/kg a day for periods ranging from 9 to 18 months. The drug produced worthwhile clinical improvement in all, with marked beneficial effects on polyuria, polydipsia, and general wellbeing. Clearance studies performed under conditions of maximal water diuresis showed that proximal tubular sodium reabsorption was increased in all children, with consequent reduction in sodium delivery to the distal nephron leading to reduced free water clearance and distal tubular cation exchange. Plasma sodium and potassium concentrations became normal in all patients, with improvement in phosphate and bicarbonate concentrations in one. Renal function continued to deteriorate, but without obvious acceleration of the process by the drug. We were unable to demonstrate a beneficial effect on growth; nevertheless, indomethacin is a useful adjunct to the symptomatic treatment of children with severe nephropathic cystinosis.
The specific metabolic defect underlying nephropathic cystinosis has not been identified, and no treatment has yet been shown convincingly to arrest, or even retard, the progression of the disease to end stage renal failure.1-3 Recent reports of a possible beneficial effect of cysteamine47 and phosphocysteamine8 must be regarded as preliminary and in need of confirmation by longer-term studies. Some palliation of the metabolic effects of the Fanconi syndrome is usually possible, and the judicious use of modern vitamin D metabolites910 is certainly of benefit in the treatment of hypophosphataemic rickets; nevertheless, affected children rarely thrive and the results of symptomatic therapy are less than satisfactory, particularly as regards growth. Reports of the sodium-and waterretaining properties of prostaglandin synthetase inhibitors in various conditionsll-'4 prompted us to investigate the effects of indomethacin on renal function and clinical progress in 3 cystinotic children.
Case reports Case 1. A girl, was investigated at age 4 years for long-standing polyuria, polydipsia, and hypokalaemia. The diagnosis of cystinosis was established by the finding of typical ophthalmoscopic and bone marrow appearances. Her growth was the least severely affected of the 3 patients at the time of diagnosis; at 4 years and 2 months her height was 97 5 cm and her weight 13.25 kg. Her treatment before the study was 6 effervescent potassium tablets daily and dihydrotachysterol 0 25-05 mg daily. At the time of starting indomethacin she was found to be hypothyroid and L-thyroxine 0 1 mg daily was given.
Case 2. Also a girl, failed to thrive from age 2 years with polyuria, polydipsia, and photophobia. Corneal and bone marrow examination confirmed the diagnosis of cystinosis when she was 3 -. For the next 2 years she was treated with vitamin D (calciferol) 6000-60000 units daily, a mixture of sodium and potassium citrate in varying doses, and energy supplements. L-thyroxine 0 1 mg daily was added at 6 years 7 months. At entry into the study aged 5 years 11 months her height was 99 cm and her weight 13 5 kg.
Case 3. A boy, was the most severely affected child studied. Polyuria, polydipsia, and severe growth retardation began in the first year of life. During an episode of dehydration at age 14 months crystals were noted in the cornea, and characteristic bone marrow appearances were seen a little later. When first seen at Guy's Hospital aged 8 years 5 months his height was 91 4 cm and his weight 13 2 kg. His treatment before the study was 1-a.-hydroxycholecalciferol 0 5 mg daily, sodium bicarbonate 6 mmol, and potassium bicarbonate 6 mmol four times daily. L-thyroxine 0 1 mg was added at 8 years 11 months. Methods Each patient was studied twice, before and after 2 weeks' treatment with indomethacin 2-3 mg/kg a day, treatment being continued through the second study period. The following protocol was followed on both occasions.
Blood and urine samples were obtained at the beginning of the study for routine biochemistry and inulin blanks. After a bolus injection of 1 ml/kg, a constant infusion of 10% inulin solution was maintained throughout the study at a rate calculated to give a plasma concentration of 25-35 mg/100 ml. A period of 30-40 minutes was allowed for the inulin to equilibrate, during which water was administered in a dose of 600-800 ml/m2 body surface area to induce maximal water diuresis. The diuresis was maintained by replacing voided urine with equal volumes of water until the investigation was complete. Two or three consecutive 20-minute urine specimens were collected; the high rate of urine flow enabled all the children to comply with this requirement without difficulty. Heparinised blood specimens were obtained at the midpoint of each 20-minute collection period; constant inulin concentrations were achieved in all studies. Extracellular fluid volume expansion was then induced by the intravenous infusion of isotonic saline 20 ml/kg over 20-40 minutes, after which two further timed urine and blood samples were obtained.
Inulin in plasma and urine was estimated by the method of Heyrovsky,'5 modified for 10 ,ul samples. Urine and plasma osmolality was measured by freezing point depression on an Advanced 3W osmometer. Plasma electrolytes were estimated by standard methodology using a Vickers multichannel automatic analyser. 
Results
Indomethacin reduced glomerular filtration rate (GFR) (C1,) from a mean of 28 9 to 19.5 ml/min Table. The effect of indomethacin on the reabsorption of water and sodium in the proximal tubular is illustrated in Fig. 1 ; at all levels of GFR the drug increased the proportion of the filtered load reabsorbed in this segment (2P<0-01 for water; 2P<0-005 for sodium). Fig. 4 . Linear growth before and after the introduction of indomethacin is shown in Fig. 5 . 
Discussion
Children with nephropathic cystinosis suffer growth failure, polyuria and polydipsia, hypophosphataemic rickets, and chronic electrolytic imbalance'6; these features are due, at least in part, to the presence of the renal Fanconi syndrome. Partial The present study was undertaken to investigate in more detail the effect of indomethacin on renal function, particularly renal sodium and water handling, and on the clinical progress of the disease.
The acute effect on GFR was clear and similar to that described in other conditions. The fact that saline volume expansion reversed the fall supports the view that the effect on GFR is secondary to a haemodynamic change; this would be entirely consistent with the assumption that renal prostaglandins are glomerular vasodilators. As regards the long-term effect on glomerular function, our data do not permit a firm conclusion to be drawn. In one of the 2 children in whom indomethacin was stopped there was a substantial subsequent fall in plasma creatinine, suggesting that reversible glomerular vasoconstriction persisted throughout treatment. The general trend shown by all 3 patients is similar to that seen in untreated children, and there is no evidence that the drug accelerates their inevitable decline into end stage renal failure.
The method used to investigate tubular sodium handling relies for its validity on the assumption that 'solute-free water' is generated in the distal tubule by reabsorption of sodium (with an attendant anion) without water; hence the need for water diuresis to suppress antidiuretic hormone. The distinction between proximal and distal tubule made in this way is functional rather than anatomical, the two segments meeting at the point in the ascending limb of the loop of Henle at which the tubular fluid is isotonic with respect to plasma, presumably near the corticomedullary boundary. Thus the proximal tubule, as defined in this way, includes the loop.
Analysis of tubular reabsorption of salt and water (Figs 1 and 2) shows that both proximal and distal nephron segments reabsorb a larger fraction of the sodium presented to them under the influence of indomethacin than under control conditions. The reduction in sodium delivery to the distal tubule leads to diminished tubular sodium-potassium exchange, which is probably the major cause of the hypokalaemia characteristic of the disease, and to relief of polyuria and salt wasting. These effects could be mediated in at least three ways: (1) 
